About Avitide
Avitide is a company based in Lebanon (United States) founded in 2012 was acquired by Repligen in September 2021. Avitide has raised $37.1 million across 8 funding rounds from investors including Orbimed, Repligen and Sands Capital Ventures. Avitide offers products and services including AVIPure Resins and Affinity Purification Platform. Avitide operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
- Headquarter Lebanon, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Avitide
Avitide offers a comprehensive portfolio of products and services, including AVIPure Resins and Affinity Purification Platform.
Affinity resins for purifying AAV serotypes with high recovery.
End-to-end platform for biopharmaceutical processing and supply.
People of Avitide
Unlock access to complete
Funding Insights of Avitide
Avitide has successfully raised a total of $37.1M across 8 strategic funding rounds. The most recent funding activity was a Series E round of $10 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Avitide
Avitide has secured backing from 8 investors, including venture fund investors. Prominent investors backing the company include Orbimed, Repligen and Sands Capital Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth stage tech & life sciences focused VC Firm investing in Asia and the US
|
Locked | Locked | Locked | |
|
Private equity investments are made in the UK and US.
|
Locked | Locked | Locked | |
|
US focused venture capital firm
|
Locked | Locked | Locked |
Investor details for Avitide
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Avitide
Investment portfolio details for Avitide
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Avitide
Detailed financials for Avitide
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Avitide Comparisons
Peer comparison for Avitide
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Avitide
Avitide operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
Detailed competitors of Avitide
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Avitide
Complete news archive for Avitide
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avitide
Avitide was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Avitide is headquartered in Lebanon, United States.
Avitide is a funded company, having raised a total of $37.1M across 8 funding rounds to date.
Avitide was founded in 2012 and is based in Lebanon, United States. Operations focus on the biopharmaceutical sector, where affinity purification solutions are discovered and high-capacity resins are developed for monoclonal antibodies, therapeutic proteins, and recombinant vaccines. Technology access is provided to biopharmaceutical partners, biotechnology firms, and purification product manufacturers via flexible licensing and collaboration arrangements.
Avitide's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Avitide offers AVIPure Resins and Affinity Purification Platform.
Avitide has 8 investors. Key investors include Orbimed, Repligen, Sands Capital Ventures, Mithril, and Polaris Partners.